Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daratumumab with DCEP in Multiple Myeloma with Plasmacytoma
NCT04065308Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daratumumab in multiple myeloma (MM), plasmacytoma, sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
daratumumab
03
Conditions
multiple myeloma (MM)plasmacytoma
Beyond the preview
Go deeper on NCT04065308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04065308.